Cargando…
Blood-Based Biomarkers of Neuroinflammation in Alzheimer’s Disease: A Central Role for Periphery?
Neuroinflammation represents a central feature in the development of Alzheimer’s disease (AD). The resident innate immune cells of the brain are the principal players in neuroinflammation, and their activation leads to a defensive response aimed at promoting β-amyloid (Aβ) clearance. However, it is...
Autores principales: | Angiulli, Federica, Conti, Elisa, Zoia, Chiara Paola, Da Re, Fulvio, Appollonio, Ildebrando, Ferrarese, Carlo, Tremolizzo, Lucio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464786/ https://www.ncbi.nlm.nih.gov/pubmed/34573867 http://dx.doi.org/10.3390/diagnostics11091525 |
Ejemplares similares
-
Serum DBI and biomarkers of neuroinflammation in Alzheimer’s disease and delirium
por: Conti, Elisa, et al.
Publicado: (2020) -
Predictors of response to acetylcholinesterase inhibitors in dementia: A systematic review
por: Pozzi, Federico Emanuele, et al.
Publicado: (2022) -
Tics: neurological disorders determined by a deficit in sensorimotor gating processes
por: Schilke, Edoardo Dalmato, et al.
Publicado: (2022) -
Donepezil-Induced Complex Multimodal Hallucinations: Two Cases and a Review of the Literature
por: Pozzi, Federico Emanuele, et al.
Publicado: (2022) -
Coming to Terms with a Conundrum: A Case of Primary Progressive Apraxia of Speech due to Corticobasal Degeneration?
por: Karantzoulis, Aristotelis, et al.
Publicado: (2021)